{"id":9492,"date":"2026-02-16T17:31:59","date_gmt":"2026-02-16T09:31:59","guid":{"rendered":"https:\/\/regask.com\/?p=9492"},"modified":"2026-02-16T17:31:59","modified_gmt":"2026-02-16T09:31:59","slug":"lagence-australienne-tga-met-a-jour-ses-recommandations-concernant-les-exigences-en-matiere-de-preuves-relatives-aux-logiciels-pour-dispositifs-medicaux-dotes-dia-et-aux-exigences-de-l03","status":"publish","type":"post","link":"https:\/\/regask.com\/fr\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/","title":{"rendered":"L\u2019Agence australienne des produits th\u00e9rapeutiques (TGA) met \u00e0 jour ses recommandations concernant les dispositifs m\u00e9dicaux utilisant l\u2019IA\u2026"},"content":{"rendered":"<p>Sur <strong>5 f\u00e9vrier 2026<\/strong>, le <strong>Administration des produits th\u00e9rapeutiques (TGA)<\/strong> des directives mises \u00e0 jour ont \u00e9t\u00e9 publi\u00e9es afin de clarifier comment <strong>logiciel bas\u00e9 sur l&#039;intelligence artificielle<\/strong> Ce dispositif est r\u00e9glement\u00e9 comme dispositif m\u00e9dical en Australie. Cette mise \u00e0 jour concerne les organismes qui d\u00e9veloppent, fournissent ou assurent la maintenance de logiciels pour dispositifs m\u00e9dicaux bas\u00e9s sur l&#039;IA et pr\u00e9cise les exigences en mati\u00e8re de classification r\u00e9glementaire, de production de preuves et de gestion du cycle de vie.<\/p>\n<div class=\"row\"  id=\"row-16700117\">\n\n\t<div id=\"col-157392922\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-1474834675\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1474834675 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>D\u00e9tails de la mise \u00e0 jour<\/h2>\n\t<div id=\"gap-1878620233\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1878620233 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Les directives mises \u00e0 jour pr\u00e9cisent que <strong>Les logiciels utilisant l&#039;IA sont r\u00e9glement\u00e9s comme des dispositifs m\u00e9dicaux en fonction de leur finalit\u00e9.,<\/strong> ind\u00e9pendamment de la technologie sous-jacente ou de la plateforme de distribution. Logiciel destin\u00e9 \u00e0 <strong>diagnostic, surveillance ou traitement<\/strong> doit \u00eatre inclus dans le <strong>Registre australien des produits th\u00e9rapeutiques (ARTG)<\/strong> avant qu&#039;il puisse \u00eatre distribu\u00e9 en Australie.<\/p>\n<p>Les lignes directrices expliquent les obligations des fabricants en mati\u00e8re de gestion <strong>mises \u00e0 jour logicielles et d\u00e9rive des objectifs,<\/strong> soulignant que les modifications qui alt\u00e8rent l&#039;utilisation pr\u00e9vue ou les performances peuvent engendrer le besoin de <strong>Approbation r\u00e9glementaire avant la mise sur le march\u00e9.<\/strong> Il aborde \u00e9galement <strong>utilisation hors indication,<\/strong> indiquant que lorsque de tels usages sont d\u00e9tect\u00e9s, les fabricants sont tenus soit de les restreindre, soit de demander leur inscription \u00e0 l&#039;ARTG pour la nouvelle indication.<\/p>\n<p>En ce qui concerne la production de preuves, la TGA clarifie les attentes relatives \u00e0 <strong>donn\u00e9es synth\u00e9tiques,<\/strong> notant que, bien qu&#039;elle puisse \u00eatre utilis\u00e9e pour compl\u00e9ter les donn\u00e9es cliniques, <strong>ne peut pas remplacer les donn\u00e9es cliniques r\u00e9elles.<\/strong> Lorsque des donn\u00e9es synth\u00e9tiques sont utilis\u00e9es pour la validation, les fabricants doivent documenter \u00e0 la fois les <strong>justification de son utilisation<\/strong> et le<strong> m\u00e9thodes utilis\u00e9es pour le g\u00e9n\u00e9rer.\u00a0<\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-157392922 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-103716918\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Date d&#039;entr\u00e9e en vigueur<\/h2>\n\t<div id=\"gap-110777559\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-110777559 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Les lignes directrices actualis\u00e9es de la TGA relatives aux logiciels pour dispositifs m\u00e9dicaux dot\u00e9s d&#039;IA s&#039;appliquent \u00e0 compter de <strong>5 f\u00e9vrier 2026. <\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-103716918 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-409176441\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Pourquoi c&#039;est important<\/h2>\n\t<div id=\"gap-1409549854\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1409549854 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Cette mise \u00e0 jour apporte des pr\u00e9cisions r\u00e9glementaires sur l&#039;\u00e9valuation, la maintenance et la documentation des logiciels de dispositifs m\u00e9dicaux pilot\u00e9s par l&#039;IA tout au long de leur cycle de vie. En d\u00e9finissant des attentes plus claires concernant les technologies de sant\u00e9 num\u00e9rique, la gestion des mises \u00e0 jour et les normes de documentation, ce guide favorise une harmonisation r\u00e9glementaire plus coh\u00e9rente, tout en visant \u00e0 r\u00e9duire l&#039;incertitude et les contraintes de conformit\u00e9 inutiles pour les acteurs concern\u00e9s.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-409176441 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-463109773\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>\u00c0 qui cela s&#039;adresse-t-il ?<\/h2>\n\t<div id=\"gap-1201470908\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1201470908 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Ces recommandations concernent les \u00e9quipes charg\u00e9es des affaires r\u00e9glementaires, de l&#039;assurance qualit\u00e9, de la s\u00e9curit\u00e9 des patients, des affaires juridiques et de la conformit\u00e9, du commerce et du marketing, ainsi que de la recherche et du d\u00e9veloppement impliqu\u00e9es dans le d\u00e9veloppement et la gestion du cycle de vie des logiciels de dispositifs m\u00e9dicaux bas\u00e9s sur l&#039;IA en Australie.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-463109773 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1362025295\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Prochaines \u00e9tapes<\/h2>\n\t<div id=\"gap-30143402\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-30143402 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Les organisations devraient examiner les produits logiciels actuels et en d\u00e9veloppement int\u00e9grant l&#039;IA afin de confirmer leur conformit\u00e9 avec les exigences clarifi\u00e9es. <strong>Crit\u00e8res d&#039;inclusion de l&#039;ARTG<\/strong> et les attentes en mati\u00e8re de documentation. Processus internes de gestion <strong>mises \u00e0 jour logicielles<\/strong> et <strong>d\u00e9tection d&#039;utilisation hors indication<\/strong> Il convient de les \u00e9valuer afin de s&#039;assurer qu&#039;elles respectent les directives mises \u00e0 jour, et les strat\u00e9gies de collecte de donn\u00e9es probantes doivent \u00eatre revues lorsque cela s&#039;av\u00e8re n\u00e9cessaire. <strong>donn\u00e9es synth\u00e9tiques<\/strong> est utilis\u00e9 dans la validation.<\/p>\n<p>Face \u00e0 l&#039;\u00e9volution constante des exigences r\u00e9glementaires concernant les dispositifs m\u00e9dicaux pilot\u00e9s par l&#039;IA, il est essentiel de se tenir inform\u00e9 des mises \u00e0 jour des directives. <strong><a href=\"http:\/\/regask.com\/fr\/\">RegASK<\/a> est une plateforme de pointe d&#039;intelligence r\u00e9glementaire et d&#039;orchestration des flux de travail bas\u00e9e sur l&#039;IA agentique, qui permet aux organisations internationales des secteurs fortement r\u00e9glement\u00e9s, tels que les produits de consommation et les sciences de la vie, d&#039;anticiper les complexit\u00e9s r\u00e9glementaires. En combinant une IA agentique avanc\u00e9e et l&#039;expertise de sp\u00e9cialistes, <a href=\"http:\/\/regask.com\/fr\/\">RegASK<\/a><\/strong> <strong>Elle fournit en temps opportun des informations pr\u00e9dictives exploitables et une automatisation de bout en bout, rationalisant les processus de conformit\u00e9, att\u00e9nuant les risques et acc\u00e9l\u00e9rant l&#039;acc\u00e8s au march\u00e9 dans plus de 160 pays.<\/strong> <a href=\"http:\/\/regask.com\/fr\/\"><strong>En savoir plus<\/strong><\/a> ou <a href=\"https:\/\/regask.com\/fr\/\"><strong>r\u00e9servez une d\u00e9mo maintenant.\u00a0<\/strong><\/a><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1362025295 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-1714213239\">\n\n\t<div id=\"col-742660595\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<div class=\"is-divider divider clearfix\" style=\"margin-top:2em;margin-bottom:2em;max-width:20%;height:1px;background-color:#a5acd9;\"><\/div>\n<h3>FAQ<\/h3>\n\t<div id=\"gap-1952284621\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1952284621 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4>Quand les logiciels utilisant l&#039;IA seront-ils r\u00e9glement\u00e9s comme dispositifs m\u00e9dicaux en Australie\u00a0?<\/h4>\n\t<div id=\"gap-264121265\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-264121265 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Les logiciels utilisant l&#039;IA sont r\u00e9glement\u00e9s comme des dispositifs m\u00e9dicaux lorsque leurs <strong>but pr\u00e9vu<\/strong> est destin\u00e9 au diagnostic, au suivi ou au traitement, quelle que soit la technologie ou la plateforme utilis\u00e9e.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-742660595 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1301198693\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>L&#039;inclusion dans l&#039;ARTG est-elle requise pour les logiciels de dispositifs m\u00e9dicaux bas\u00e9s sur l&#039;IA\u00a0?<\/h4>\n\t<div id=\"gap-299296708\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-299296708 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Oui. Les logiciels utilisant l&#039;IA et destin\u00e9s au diagnostic, au suivi ou au traitement doivent \u00eatre inclus dans le <strong>ARTG avant la fourniture<\/strong> en Australie.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1301198693 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1818627874\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>Les donn\u00e9es synth\u00e9tiques peuvent-elles remplacer les preuves cliniques selon les nouvelles directives\u00a0?<\/h4>\n\t<div id=\"gap-1525506137\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1525506137 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Non. Les donn\u00e9es synth\u00e9tiques peuvent <strong>compl\u00e9ter mais ne pas remplacer les donn\u00e9es cliniques,<\/strong> et son utilisation doit \u00eatre justifi\u00e9e et document\u00e9e.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1818627874 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1550750097\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>Comment RegASK peut-il aider les \u00e9quipes \u00e0 g\u00e9rer la conformit\u00e9 des dispositifs m\u00e9dicaux dot\u00e9s d&#039;IA\u00a0?<\/h4>\n\t<div id=\"gap-1078415171\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1078415171 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><a href=\"http:\/\/regask.com\/fr\/\"><strong>RegASK<\/strong><\/a> aide les organisations \u00e0 suivre les mises \u00e0 jour r\u00e9glementaires comme ces directives de la TGA, \u00e0 \u00e9valuer leur impact sur l&#039;ensemble de leurs portefeuilles de produits et \u00e0 coordonner des r\u00e9ponses conformes gr\u00e2ce \u00e0 des informations bas\u00e9es sur l&#039;IA combin\u00e9es \u00e0 une surveillance r\u00e9glementaire experte.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1550750097 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>On February 5, 2026, the Therapeutic Goods Administration (TGA) published updated guidance clarifying how artificial intelligence enabled software is regulated as a medical device in Australia. The update affects organizations developing, supplying, or maintaining AI-driven medical device software and outlines clearer expectations for regulatory classification, evidence generation, and lifecycle management.<\/p>","protected":false},"author":43,"featured_media":9493,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33,511,39],"tags":[],"class_list":["post-9492","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-australia-regulations","category-medical-devices-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Australia TGA Updates Guidance on AI-Enabled Devices<\/title>\n<meta name=\"description\" content=\"Australia TGA updates guidance on AI-enabled medical device software, clarifying ARTG evidence requirements for manufacturers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/fr\/lagence-australienne-tga-met-a-jour-ses-recommandations-concernant-les-exigences-en-matiere-de-preuves-relatives-aux-logiciels-pour-dispositifs-medicaux-dotes-dia-et-aux-exigences-de-l03\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Australia TGA Updates Guidance on AI-Enabled Medical Device Software and ARTG Evidence Requirements\" \/>\n<meta property=\"og:description\" content=\"Australia TGA updates guidance on AI-enabled medical device software, clarifying ARTG evidence requirements for manufacturers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/fr\/lagence-australienne-tga-met-a-jour-ses-recommandations-concernant-les-exigences-en-matiere-de-preuves-relatives-aux-logiciels-pour-dispositifs-medicaux-dotes-dia-et-aux-exigences-de-l03\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-16T09:31:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png\" \/>\n\t<meta property=\"og:image:width\" content=\"904\" \/>\n\t<meta property=\"og:image:height\" content=\"622\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"Australia TGA Updates Guidance on AI-Enabled Medical De&hellip;\",\"datePublished\":\"2026-02-16T09:31:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/\"},\"wordCount\":776,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png\",\"articleSection\":[\"Regulatory News\",\"Australia\",\"Medical Devices\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/\",\"name\":\"Australia TGA Updates Guidance on AI-Enabled Devices\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png\",\"datePublished\":\"2026-02-16T09:31:59+00:00\",\"description\":\"Australia TGA updates guidance on AI-enabled medical device software, clarifying ARTG evidence requirements for manufacturers.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png\",\"width\":904,\"height\":622,\"caption\":\"Australia Tga Updates Guidance Ai Enabled Medical Device Software Artg Evidence Requirements\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"L&#039;agence australienne de r\u00e9glementation des produits th\u00e9rapeutiques (TGA) met \u00e0 jour ses recommandations concernant les appareils dot\u00e9s d&#039;intelligence artificielle.","description":"L\u2019agence australienne TGA met \u00e0 jour ses directives sur les logiciels pour dispositifs m\u00e9dicaux utilisant l\u2019IA, clarifiant les exigences de preuve de l\u2019ARTG pour les fabricants.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/fr\/lagence-australienne-tga-met-a-jour-ses-recommandations-concernant-les-exigences-en-matiere-de-preuves-relatives-aux-logiciels-pour-dispositifs-medicaux-dotes-dia-et-aux-exigences-de-l03\/","og_locale":"fr_FR","og_type":"article","og_title":"Australia TGA Updates Guidance on AI-Enabled Medical Device Software and ARTG Evidence Requirements","og_description":"Australia TGA updates guidance on AI-enabled medical device software, clarifying ARTG evidence requirements for manufacturers.","og_url":"https:\/\/regask.com\/fr\/lagence-australienne-tga-met-a-jour-ses-recommandations-concernant-les-exigences-en-matiere-de-preuves-relatives-aux-logiciels-pour-dispositifs-medicaux-dotes-dia-et-aux-exigences-de-l03\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-02-16T09:31:59+00:00","og_image":[{"width":904,"height":622,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Reva Ananda","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/#article","isPartOf":{"@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"Australia TGA Updates Guidance on AI-Enabled Medical De&hellip;","datePublished":"2026-02-16T09:31:59+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/"},"wordCount":776,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png","articleSection":["Regulatory News","Australia","Medical Devices"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/","url":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/","name":"L&#039;agence australienne de r\u00e9glementation des produits th\u00e9rapeutiques (TGA) met \u00e0 jour ses recommandations concernant les appareils dot\u00e9s d&#039;intelligence artificielle.","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png","datePublished":"2026-02-16T09:31:59+00:00","description":"L\u2019agence australienne TGA met \u00e0 jour ses directives sur les logiciels pour dispositifs m\u00e9dicaux utilisant l\u2019IA, clarifiant les exigences de preuve de l\u2019ARTG pour les fabricants.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/australia-tga-updates-guidance-on-ai-enabled-medical-device-software-and-artg-evidence-requirements\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/australia-tga-updates-guidance-ai-enabled-medical-device-software-artg-evidence-requirements.png","width":904,"height":622,"caption":"Australia Tga Updates Guidance Ai Enabled Medical Device Software Artg Evidence Requirements"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Le syst\u00e8me d&#039;exploitation d&#039;IA r\u00e9glementaire pour les \u00e9quipes performantes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"Reva Ananda"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/9492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/comments?post=9492"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/9492\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media\/9493"}],"wp:attachment":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media?parent=9492"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/categories?post=9492"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/tags?post=9492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}